Parkinson's disease (PD) is the second most common form of neurodegenerative disease and afflicts more than 10 million people worldwide. While current therapies address disease symptoms, they do not ...

New clinical data from the STEM-PD Phase I/II clinical trial have been presented at the ISSCR 2026 Annual Meeting. The study ...

A Yale researcher told Newsweek one newly identified Parkinson's target is already being tested in trials.

Parkinson's disease screening may one day need just one tear, as a new graphene sensor detects dopamine with near-perfect ...

Experts advocate for greater access to incision-free MRgFUS treatment for Parkinson’s in India, enhancing patient quality of ...

A landmark study led from Lund, Sweden, has shown that transplanting stem-cell derived dopamine progenitor cells into the ...

Parkinson's disease may spread through the brain with the help of two proteins found on the surface of motor neurons, according to new research from Yale School of Medicine (YSM). The discovery could ...

Stacked appointments, new medications and meeting with the requirements of insurance policies are routine for those living with Parkinson’s disease. In rural states like Wyoming, patients ...

Researchers from the Shibaura Institute of Technology recently created a new vitamin K-based compound that may help the brain regenerate lost neurons. The compound combined vitamin K with vitamin ...